IRIS
LLEO DE NALDA, Ana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.502
AS - Asia 4.931
EU - Europa 1.660
SA - Sud America 960
AF - Africa 262
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 15.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.317
SG - Singapore 2.900
CN - Cina 894
BR - Brasile 793
VN - Vietnam 457
IT - Italia 356
FI - Finlandia 286
IE - Irlanda 208
DE - Germania 172
NG - Nigeria 170
HK - Hong Kong 139
FR - Francia 126
GB - Regno Unito 111
IN - India 96
CA - Canada 95
SE - Svezia 94
NL - Olanda 79
AR - Argentina 64
BD - Bangladesh 60
AE - Emirati Arabi Uniti 52
TR - Turchia 50
MX - Messico 45
IQ - Iraq 43
RU - Federazione Russa 43
ID - Indonesia 31
PK - Pakistan 29
BE - Belgio 28
ZA - Sudafrica 27
EC - Ecuador 25
PH - Filippine 22
PL - Polonia 21
UA - Ucraina 21
IL - Israele 20
JP - Giappone 20
MK - Macedonia 20
ES - Italia 19
CL - Cile 17
CZ - Repubblica Ceca 17
CO - Colombia 15
MA - Marocco 15
VE - Venezuela 15
SA - Arabia Saudita 13
UZ - Uzbekistan 13
MY - Malesia 12
PY - Paraguay 12
ET - Etiopia 11
NP - Nepal 11
JO - Giordania 10
KZ - Kazakistan 10
AU - Australia 9
KE - Kenya 9
AT - Austria 8
DZ - Algeria 8
RO - Romania 8
TT - Trinidad e Tobago 8
DO - Repubblica Dominicana 7
EG - Egitto 7
KR - Corea 7
PE - Perù 7
UY - Uruguay 7
AZ - Azerbaigian 6
BB - Barbados 6
GR - Grecia 6
JM - Giamaica 6
OM - Oman 6
RS - Serbia 6
TN - Tunisia 6
CR - Costa Rica 5
IR - Iran 5
LT - Lituania 5
AL - Albania 4
CH - Svizzera 4
HN - Honduras 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
EU - Europa 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
AM - Armenia 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
Totale 15.315
Salva come PNG Salva come JPEG
Città #
Singapore 1.351
Chandler 957
Wilmington 826
Ashburn 557
Dallas 483
San Jose 437
The Dalles 413
Shanghai 356
San Mateo 313
Helsinki 284
Ann Arbor 266
New York 258
Beijing 218
Dublin 208
Boardman 189
Benin City 167
Lawrence 156
Princeton 155
Ho Chi Minh City 147
Leawood 141
Hong Kong 132
Milan 128
Hanoi 124
Los Angeles 101
Paris 95
São Paulo 71
Fairfield 70
Santa Clara 70
Woodbridge 70
Amsterdam 57
London 52
Seattle 44
Toronto 41
Buffalo 34
Phoenix 31
Brussels 28
Naples 28
Da Nang 27
Orem 27
Chennai 24
Council Bluffs 24
Falkenstein 24
Baghdad 22
Rome 22
Brooklyn 18
Pune 18
San Diego 18
Brasília 17
Frankfurt am Main 17
Montreal 17
Munich 17
Redwood City 17
Rio de Janeiro 17
Abbiategrasso 16
Assago 16
Charlotte 16
Dhaka 16
Haiphong 16
Stockholm 16
Kocaeli 15
Tokyo 15
Warsaw 15
Belo Horizonte 14
Johannesburg 14
Atlanta 13
Boston 13
Columbus 13
Mexico City 13
Norwalk 13
Tashkent 13
Campinas 12
Chicago 12
Porto Alegre 12
Brno 11
Guarulhos 11
Guayaquil 11
San Francisco 11
Addis Ababa 10
Denver 10
Manchester 10
Amman 9
Biên Hòa 9
Buenos Aires 9
Houston 9
Istanbul 9
Mauá 9
Skopje 9
Ankara 8
Kuala Lumpur 8
Miami 8
Ninh Bình 8
Salvador 8
Thái Nguyên 8
Chula Vista 7
City of London 7
Curitiba 7
Duque de Caxias 7
Jakarta 7
Nairobi 7
Newark 7
Totale 9.901
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 211
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? 165
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 135
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 134
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 133
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 130
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis 121
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 116
Apotopes and the biliary specificity of primary biliary cirrhosis 114
Innate Immunity and Primary Biliary Cirrhosis 113
B cell depletion therapy exacerbates murine primary biliary cirrhosis 112
Genetic associations in Italian primary sclerosing cholangitis : heterogeneity across Europe defines a critical role for HLA-C 110
COVID-19 and liver cancer clinical trials: not everything is lost 108
Lights and Shadows on Fibrates as Second-Line Therapy of Primary Biliary Cholangitis 108
Mapping the human genetic architecture of COVID-19 107
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 106
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis 106
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 106
Autophagy: highlighting a novel player in the autoimmunity scenario 105
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 104
The consequences of apoptosis in autoimmunity 104
Clinical Outcomes in the Second versus First Pandemic Wave in Italy: Impact of Hospital Changes and Reorganization 104
Interferon α and its contribution to autoimmunity 102
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 101
Prevalence and clinical significance of intrahepatic cholangiocellular carcinoma with radiological enhancement pattern mimicking hepatocellular carcinoma 101
Is autoimmunity a matter of sex? 99
The X chromosome and immune associated genes 98
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 98
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis 96
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis 96
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 95
Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario 95
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 95
Definition of human autoimmunity - autoantibodies versus autoimmune disease 94
Advances in pharmacotherapy for primary biliary cirrhosis 94
High mortality in COVID-19 patients with mild respiratory disease 94
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 93
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 93
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review 91
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 91
HLA Class II antigens associated with lupus nephritis in Italian SLE patients 90
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature 90
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 90
Autoimmunity and Turner's syndrome 90
Safety of vedolizumab in liver transplant recipients: A systematic review 90
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 90
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis 89
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 88
The risk of Liver Cancer in Autoimmune Liver Diseases 88
Benign liver tumors: Diagnostics and treatment 88
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 87
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals 87
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 87
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C 87
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 86
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase 86
Primary biliary cholangitis: a comprehensive overview. 85
Etiopathogenesis of primary biliary cirrhosis 85
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 85
Changes in the Epidemiology of Primary Biliary Cholangitis 84
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 84
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study 84
Making sense of Autoantibodies in Cholestatic Liver Diseases 83
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine 83
Y chromosome loss in male patients with primary biliary cirrhosis 82
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 82
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 82
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 82
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 81
Role of liver biopsy in hepatocellular carcinoma 81
Antimitochondrial Antibodies: from Bench to Bedside 81
The X-Factor in Primary Biliary Cirrhosis: Monosomy X and Xenobiotics 80
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 80
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 80
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference 79
Liver Injury Induced by Immune Checkpoint Inhibitors: An Affordable Risk of Cancer Therapy? 79
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes 79
A second update on mapping the human genetic architecture of COVID-19 78
Letter to the Editor: might denosumab fit in PBC treatment? 78
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 78
The immunological potential of galectin-1 and -3 77
Primary biliary cholangitis 77
Interpreting serological tests in diagnosing autoimmune liver diseases 76
Mediterranean diet and NAFLD: What we know and questions that still need to be answered 76
Genetics and epigenetics of primary biliary cirrhosis 76
Evolving trends in female to male incidence and male mortality of primary biliary cholangitis 76
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 76
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 76
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Shotgun Proteomics: Identification of Unique Protein Profiles of Apoptotic Bodies From Biliary Epithelial Cells 75
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 75
Modulation of CD4(+) T cell responses following splenectomy in hepatitis C virus-related liver cirrhosis 75
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications 75
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 75
Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals 74
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 74
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 73
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario 73
Coronary flow reserve is an innovative tool for the early detection of cardiovascular dysfunction in primary biliary cholangitis patients. 73
Totale 9.250
Salva come PNG Salva come JPEG
Categoria #
all - tutte 100.028
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 100.028
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021163 0 0 0 0 0 0 0 0 0 0 0 163
2021/2022833 30 10 15 178 8 11 22 109 89 92 201 68
2022/20232.567 349 128 244 319 234 221 13 187 459 205 162 46
2023/20241.616 120 146 347 73 46 220 118 99 34 32 133 248
2024/20252.514 55 51 22 60 61 317 224 254 349 566 275 280
2025/20266.497 900 410 504 602 199 255 1.781 327 389 417 326 387
Totale 15.567